ExpreS2ion Biotechnologies: AdaptVac, Part of Consortium Receiving USD 12.4M in Grants
19 juni, 11:31
19 juni, 11:31
AdaptVac, in which ExpreS2ion holds a 34% stake, is in the spotlight today. First, as part of a consortium awarded USD 12.4 million in grants, and second, through a press release picked up by several newspapers regarding the potential of their technology to address some of the drawbacks of mRNA vaccines.
19 juni, 11:31
AdaptVac, in which ExpreS2ion holds a 34% stake, is in the spotlight today. First, as part of a consortium awarded USD 12.4 million in grants, and second, through a press release picked up by several newspapers regarding the potential of their technology to address some of the drawbacks of mRNA vaccines.
Analyser

Aktieråd


SBB

Inflationen
Analyser

Aktieråd


SBB

Inflationen
1 DAG %
Senast

Stockholmsbörsen
12 december, 17:47
Börsen föll tillbaka – stänger veckan rött
Castellum
12 december, 17:27
Castellums VD shoppar loss
Nordea Bank
12 december, 17:02
Storbankerna är dyrare än vanligt – vi slopar köpråden
blankning
12 december, 16:41
Här är de mest blankade aktierna just nu
Coffee Stain Group B
12 december, 14:25
Analys: Uppsidan lockar i Embracers avknoppning
OMX Stockholm 30
1 DAG %
Senast
2 821,01